The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

By Meagan Parrish • July 7, 2022

Woman of the Week: CinCor Pharma's Terry Coelho

From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

By Taren Grom • July 6, 2022

Explore the Trendline➔

Artificial intelligence & machine learning

After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.

By PharmaVoice staff

Woman of the Week: Novartis' Marie-France Tschudin

How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

By Taren Grom • June 29, 2022

The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

By Michael Gibney • June 29, 2022

Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires

The latest personnel changes from around the industry.

By Karissa Waddick • June 29, 2022

From vineyards to antivirals, Gilly Regev brings creative thinking to science

The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

By Alexandra Pecci • June 27, 2022

4 tips for landing your next C-suite role in pharma

Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

By Meagan Parrish • June 23, 2022

Woman of the Week: Kronos Bio's Barbara Kosacz

Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.

By Taren Grom • June 21, 2022

The public health sleuth

In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.

By Alexandra Pecci • June 21, 2022

#DIA2022: How the industry's top regulator views the future of healthcare

In the evolution of healthcare, data is the linchpin to making drug development more efficient.

By Michael Gibney • June 21, 2022

A patient-funded ALS drug offers hope where few treatments exist

Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

By Kelly Bilodeau • June 15, 2022

Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

By Alexandra Pecci • June 14, 2022

Making moves: Civica, Astellas, Inozyme and more announce key new hires

The latest hiring moves from Civica, Astella, Inozyme and the Flagship Pioneering-founded Tessera Therapeutics. 

By Karissa Waddick • June 13, 2022

First 90 Days: Editas Medicine’s Gilmore O’Neill

The first-time CEO is flexing new muscles as he steers the gene editing company through clinical trials and beyond.

By Michael Gibney • June 13, 2022

4 steps to making data work for you

"Analytics" can sometimes feel like a four-letter word. Here are four steps to building a successful data-driven culture. No data science degree required.

June 13, 2022

Woman of the Week: Janssen’s Najat Khan

Janssen’s Najat Khan, Ph.D., chief data science officer and global head of strategy and operations, shares how the company is using next-gen tech to ‘reimagine’ medicine.

By Taren Grom • June 8, 2022

As cancer innovations thrive, patient access is the next piece of the puzzle

Why enhanced clinical trials and diagnostics are keys to boosting patient access to cancer care.

By Michael Gibney • June 8, 2022

After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

By Alexandra Pecci • June 7, 2022

First 90 Days: Janssen Immunology’s David Jimenez

The long-time company man discusses the mega-drugmaker’s plans for growth and why, if you meet with him, you should plan on sipping coffee.

By Taren Grom • June 6, 2022

How to build a cancer pipeline: Big Pharma oncology heads on driving science forward

Executives leading the cancer departments at J&J, Merck and Takeda chime in on what it takes to construct a successful and sustainable oncology drug pipeline.

By Michael Gibney • June 6, 2022

Flagship's creative approach to finding the next big idea in biopharma

Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

By Alexandra Pecci • June 1, 2022

Woman of the Week: OcuTerra Therapeutics' Kerrie Brady

The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.

By Taren Grom • June 1, 2022

First 90 Days: Sosei Heptares’ Chris Cargill

The company’s new CEO is looking to drive growth through collaboration and transparency.

By Kim Ribbink • May 31, 2022

PBMs under fire for drug prices defend their worth

A new Senate bill is putting PBMs in the crosshairs of lawmakers — but they argue that they're more than just middlemen.

By Michael Gibney • May 26, 2022

Making moves: Inovio, Veru, MindMed and more announce key new hires

The latest career moves in the biopharma industry from Veru, MindMed, Horizon Therapeutics and Inovio. 

By Karissa Waddick • May 25, 2022